UnknownNot Applicable

Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals)

708 participantsStarted 2012-03-27

Plain-language summary

This study investigates carriage rate and risk factors for acquiring multiresistant bacteria (ESBL producing E.coli and K.pneumoniae, carbapenem-resistant and multidrug resistant P.aeruginosa, MRSA and VRE) in hospitalised patients and healthy volunteers.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

I group Hospitalised patients Inclusion Criteria * MDR bacteria (listed above) isolated from clinical specimen * hospitalisation to the Tartu University Hospital or North Estonia Medical Centre or West Tallinn Central Hospital or East-Tallinn Central Hospital or The Hospital of Reconstructive Surgery II group Healthy volunteers Inclusion Criteria * age \>6 months * have not received any antibacterial treatment in previous 3 months * have not been hospitalised in previous 3 months III group Dog owners Inclusion Criteria * age \>6 months * have not received any antibacterial treatment in previous 3 months * have not been hospitalised in previous 3 months * owning a dog IV group veterinarians Inclusion Criteria * have not received any antibacterial treatment in previous 3 months * have not been hospitaliZed in previous 3 months * working as a veterinarian V group pig farmers Inclusion Criteria * have not received any antibacterial treatment in previous 3 months * have not been hospitalized in previous 3 months * occupation as a pig farmer

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Colonization rate with multiresistant (MDR) bacteria in hospitalized patients

Timeframe: March 2012 - March 2014

Colonization rate with multiresistant (MDR) bacteria in healthy humans

Timeframe: March 2012 - March 2014

Trial details

NCT IDNCT03343119

SponsorUniversity of Tartu

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01-30

View on ClinicalTrials.gov More ESBL Producing E.Coli trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.